Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sara Stridh, Fredrik Palm, Tomoko Takahashi, Mayumi Ikegami-Kawai & Peter Hansell. (2015) Inhibition of mTOR activity in diabetes mellitus reduces proteinuria but not renal accumulation of hyaluronan. Upsala Journal of Medical Sciences 120:4, pages 233-240.
Read now
Read now
Articles from other publishers (6)
Baris Afsar & Rengin Elsurer Afsar. (2023) The role of glycosaminoglycans in blood pressure regulation. Microcirculation 30:8.
Crossref
Crossref
Loay Salman, Laisel Martinez, Geovani Faddoul, Christina Manning, Karim Ali, Maya Salman & Roberto Vazquez-Padron. (2023) Hyaluronan Inhibition as a Therapeutic Target for Diabetic Kidney Disease: What Is Next?. Kidney360 4:6, pages e851-e860.
Crossref
Crossref
B. Madhoolika, N.V. Anil Kumar & S. Balaji. (2017)
In vitro
analysis of 4-methylumbelliferone as a sole carbon source for
Lactobacillus helveticus
2126
. Letters in Applied Microbiology 65:3, pages 249-255.
Crossref
Crossref
Giancarlo Ghiselli. (2017) Drug-Mediated Regulation of Glycosaminoglycan Biosynthesis. Medicinal Research Reviews 37:5, pages 1051-1094.
Crossref
Crossref
P. Hansell & F. Palm. (2015) A role for the extracellular matrix component hyaluronan in kidney dysfunction during ACE-inhibitor fetopathy. Acta Physiologica 213:4, pages 795-804.
Crossref
Crossref
Nadine Nagy, Hedwich F. Kuipers, Adam R. Frymoyer, Heather D. Ishak, Jennifer B. Bollyky, Thomas N. Wight & Paul L. Bollyky. (2015) 4-Methylumbelliferone Treatment and Hyaluronan Inhibition as a Therapeutic Strategy in Inflammation, Autoimmunity, and Cancer. Frontiers in Immunology 6.
Crossref
Crossref